KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Amortization of Deferred Charges (2017 - 2025)

Historic Amortization of Deferred Charges for Evolent Health (EVH) over the last 9 years, with Q3 2025 value amounting to $3.2 million.

  • Evolent Health's Amortization of Deferred Charges rose 14754.86% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 million, marking a year-over-year increase of 542.56%. This contributed to the annual value of $4.8 million for FY2024, which is 5615.86% down from last year.
  • Per Evolent Health's latest filing, its Amortization of Deferred Charges stood at $3.2 million for Q3 2025, which was up 14754.86% from $1.3 million recorded in Q2 2025.
  • Evolent Health's Amortization of Deferred Charges' 5-year high stood at $11.7 million during Q1 2022, with a 5-year trough of $1.1 million in Q2 2024.
  • In the last 5 years, Evolent Health's Amortization of Deferred Charges had a median value of $2.3 million in 2023 and averaged $3.3 million.
  • In the last 5 years, Evolent Health's Amortization of Deferred Charges surged by 16748.28% in 2022 and then crashed by 8040.89% in 2023.
  • Quarter analysis of 5 years shows Evolent Health's Amortization of Deferred Charges stood at $4.6 million in 2021, then surged by 78.39% to $8.3 million in 2022, then plummeted by 64.54% to $2.9 million in 2023, then plummeted by 59.37% to $1.2 million in 2024, then skyrocketed by 166.42% to $3.2 million in 2025.
  • Its Amortization of Deferred Charges stands at $3.2 million for Q3 2025, versus $1.3 million for Q2 2025 and $1.2 million for Q1 2025.